M
Mainz Biomed BV D
D
MYNZ
1.60000
USD
-0.21
(-11.60%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
6,103,765
العنوان: Mainz Biomed N.V.
القطاع: Healthcare
الصناعة: Diagnostics & Research
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.